Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies.

Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37

Idiotype-antiidiotype regulation. V. The requirement for immunization with antigen or monoclonal antiidiotypic antibodies for the activation of beta 2 leads to 6 and beta 2 leads to 1 polyfructosan-reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies. J Exp Med (1983) 1.07

Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A (1993) 1.00

Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J Immunol (2010) 0.83

Immunogenicity of cytopathic and noncytopathic viral vectors. J Virol (2006) 0.81

Induction and properties of syngeneic murine anti-immunoglobulin D. Proc Natl Acad Sci U S A (1988) 0.77

Suppression of follicular trapping of antigen-antibody complexes in mice treated with anti-IgM or anti-IgD antibodies from birth. Immunology (1984) 0.76

In memorium G. Jeanette Thorbecke, 1929-2001. Am J Pathol (2002) 0.75

THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56

Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93

Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med (1969) 18.89

Towards a network theory of the immune system. Ann Immunol (Paris) (1974) 16.43

Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40

Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol (1978) 13.40

Immunoglobulin spots on the surface of rabbit lymphocytes. J Exp Med (1970) 8.87

Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62

Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50

Inhibition of secondary anti-hapten responses with the hapten conjugated to type 3 pneumococcal polysaccharide. Eur J Immunol (1972) 2.14

Mouse immunoglobulin D: messenger RNA and genomic DNA sequences. Science (1980) 2.11

Suppression of synthesis of allotypically defined immunoglobulins and compensation by another sub-class of immunoglobulin. Nature (1967) 1.77

Specific antibody within lymphoid germinal center cells of mice after primary immunization with horseradish peroxidase: a light and electron microscopic study. J Exp Med (1970) 1.75

Irreversible inhibition of biotin transport in yeast by biotinyl-p-nitrophenyl ester. Proc Natl Acad Sci U S A (1971) 1.66

IgD and B cell differentiation. Immunol Rev (1977) 1.59

A myeloma hybrid producing antibody specific for an allotypic determinant on "IgD-like" molecules of the mouse. Eur J Immunol (1977) 1.41

Differential effect of neonatal injections of anti-mu or anti-delta antibodies on the synthesis of IgM, IgD, IgE, IgA, IgG1, IgG2a, IgG2b, and IgG2c immunoglobulin classes. J Immunol (1978) 1.19

The murine B cell response to TNP-polyacrylamide beads: the relationship between the epitope density of the antigen and the requirements for T cell help and surface IgD. J Immunol (1980) 1.18

In vitro studies of allotype suppression in mice. Eur J Immunol (1973) 1.17

Allotype suppression in rabbits: effects of anti-allotype antisera upon expression of immunoglobulin genes. Transplant Rev (1975) 1.12

Complete inhibition of the expression of an idiotype by a mechanism of B-cell dominance. J Exp Med (1977) 1.11

Blocking of primary in vitro antibody responses to thymus-independent and thymus-dependent antigens with antiserum specific for IgM or IgD. Proc Natl Acad Sci U S A (1978) 1.10

The anti-delta suppressed mouse. Eur J Immunol (1978) 0.94

Allelic exclusion of IgD allotypes on murine B cells. J Immunol (1980) 0.91

Allotype suppression in the chicken. I. Generation of chronic suppression in heterozygous but not in homozygous chickens. Eur J Immunol (1979) 0.87

Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation. Contemp Top Immunobiol (1978) 0.87

A role for clonal dominance in the maintenance of allotype suppression? J Exp Med (1979) 0.85

Augmentation of in vitro humoral immune responses in the mouse by an antibody to IgD. J Exp Med (1980) 0.83

Optical coherence tomography. Science (1991) 57.87

Immunoglobulin spots on the surface of rabbit lymphocytes. J Exp Med (1970) 8.87

The dynamic state of the lymphocyte membrane. Factors affecting the distribution and turnover of surface immunoglobulins. Eur J Immunol (1972) 7.05

Cellular localization of immunoglobulins with different allotypic specificities in rabbit lymphoid tissues. J Exp Med (1965) 6.93

Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05

Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62

Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol (1976) 4.52

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis (1998) 3.60

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27

Immunoglobulins as cell receptors. Ann N Y Acad Sci (1971) 3.25

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A (1991) 3.19

Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR. Nature (1992) 3.06

Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice. J Exp Med (1972) 3.02

Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01

Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol (1971) 2.86

The liver as the site of C-reactive protein formation. J Exp Med (1966) 2.76

Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A (1989) 2.74

Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science (1992) 2.57

Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol (1983) 2.38

Dendritic cells in the immune response: characteristics and recommended nomenclature (A report from the Reticuloendothelial Society Committee on Nomenclature). J Reticuloendothel Soc (1982) 2.34

Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells. J Exp Med (1972) 2.34

Specificity of cellular immune responses. Antigen concentration dependence of stimulation of DNA synthesis in vitro by specifically sensitized cells, as an expression of the binding characteristics of cellular antibody. J Exp Med (1968) 2.32

Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. J Immunol (1983) 2.29

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27

Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24

Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24

Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology (1968) 2.20

Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized. J Exp Med (1966) 2.16

Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol (1980) 2.16

Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell Immunol (1974) 2.15

Confocal examination of nonmelanoma cancers in thick skin excisions to potentially guide mohs micrographic surgery without frozen histopathology. J Invest Dermatol (2001) 2.14

Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol Rev (1980) 2.10

Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07

ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol (1994) 2.05

Specific binding of alloantigens to T cells activated in the mixed lymphocyte reaction. J Exp Med (1976) 2.04

Mechanical closure of the vocal cords with the LMA ProSeal. Br J Anaesth (2002) 2.03

Sites of synthesis of serum proteins. OI. Serum proteins produced by macrophages in vitro. J Immunol (1967) 1.96

Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J Exp Med (1966) 1.94

TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem (1999) 1.93

Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89

Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med (1967) 1.89

Sites of production of primate serum proteins associated with complement system. Proc Soc Exp Biol Med (1967) 1.88

Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts. J Exp Med (1969) 1.86

Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J Exp Med (1974) 1.86

SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83

Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits. J Immunol (1968) 1.82

A study of the 'termination' of tolerance to BSA with DNP-BSA in rabbits: relative affinities of the antibodies for the immunizing and the paralysing antigens. Immunology (1967) 1.82

Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther (2001) 1.81

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther (1996) 1.80

CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem (2000) 1.79

Synthesis of multiple immunoglobulin classes by single lymphocytes. Cold Spring Harb Symp Quant Biol (1977) 1.76

CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem (2000) 1.72

Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity (1995) 1.72

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene (2009) 1.66

Rheumatoid factor in serum of individuals exposed to asbestos. Ann N Y Acad Sci (1965) 1.65

Surface antigens of immunocompetent cells. I. Effect of theta and PC.1 alloantisera on the ability of spleen cells to transfer immune responses. J Exp Med (1970) 1.65

T-cell-derived lymphokines that induce IgM and IgG secretion in activated murine B cells. Immunol Rev (1984) 1.65

Blocking and redistribution ("capping") of antigen receptors on T and B lymphocytes by anti-immunoglobulin antibody. J Exp Med (1973) 1.63

Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61

IgM-producing tumors in the BALB-c mouse: a model for B-cell maturation. J Exp Med (1974) 1.61

The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61

Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med (1984) 1.60

Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. J Infect Dis (2000) 1.59

Beta-1C and immune globulin formation in vitro by tissues from germ-free and conventional rodents of various ages. Immunology (1967) 1.52

Immunoglobulins, antibodies and the bursa of Fabricus: induction of agammaglobulinemia and the loss of all antibody-forming capacity by hormonal bursectomy. J Immunol (1969) 1.52

Contact hypersensitivity and Langerhans cells. J Invest Dermatol (1980) 1.51

Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. Proc Natl Acad Sci U S A (1986) 1.51

Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells. J Exp Med (1979) 1.50

Staining of Langerhans cells with monoclonal antibodies to macrophages and lymphoid cells. Proc Natl Acad Sci U S A (1983) 1.50

Sites of synthesis of serum proteins. 3. Production of beta-1-C, beta-1-E and transferrin by primate and rodent cell lines. J Immunol (1967) 1.46

Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton (1999) 1.45

CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest (2000) 1.43

Immunological memory in mice. II. Cell interactions in the secondary immune response studies by means of immunoglobulin allotype markers. J Exp Med (1970) 1.42

Airway management device (AMD). Anaesthesia (2001) 1.39

Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1972) 1.39

Langerhans cells: a review of their nature with emphasis on their immunologic functions. Prog Allergy (1978) 1.37

Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37

Depressive symptoms and suicidal ideation among Mexican-origin and Anglo adolescents. J Am Acad Child Adolesc Psychiatry (1995) 1.35

Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. Am J Physiol (1994) 1.35

In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35

Ultrastructure of cells present in lymph nodes during the development of contact sensitivity. Int Arch Allergy Appl Immunol (1966) 1.34

Cellular localization of rheumatoid factor idiotypes. J Clin Invest (1982) 1.33

T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A (1998) 1.32

Studies on the serum proteins of chimeras. I. Identification and study of the site of origin of donor type serum proteins in adult rat-into-mouse chimeras. Int Arch Allergy Appl Immunol (1966) 1.31

Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. Cell Immunol (1975) 1.30

Human T cell receptor for IgM: specificity for the pentameric Fc fragment. Eur J Immunol (1976) 1.30

Spontaneous internalization of Class I major histocompatibility complex molecules in T lymphoid cells. J Exp Med (1984) 1.29

CD30 in normal and neoplastic cells. Clin Immunol (1999) 1.29

Tolerance in adult rabbits by repeated non-immunogenic doses of bovine serum albumin. Immunology (1967) 1.27

Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J Immunol (1993) 1.27

Studies on "in vitro" cytotoxicity of asbestos dusts. Med Lav (1968) 1.27

Studies on antigenic competition. J Exp Med (1969) 1.26

Effect of tolerance and immunity on antibody affinity. Transplant Rev (1972) 1.25